Skip to main content
Log in

The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians

  • SHORT COMMUNICATION
  • Published:
Neurogenetics Aims and scope Submit manuscript

ABSTRACT

Mutations in the gene for methylenetetrahydrofolate reductase (MTHFR) have been implicated as a risk factor in the formation of neural tube defects. We investigated this gene in a series of 65 sporadic American Caucasians patients with lumbosacral NTD and their unaffected parents, using both case-control design and assessment of linkage disequilibrium. We found no evidence to support mutations in MTHFR as a significant risk factor for NTD in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Consortia

Additional information

Received April 28, 1997; Revised and Accepted June 20, 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Speer, M., Worley, G., Mackey, J. et al. The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians. Neurogenetics 1, 149–150 (1997). https://doi.org/10.1007/s100480050022

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100480050022

Navigation